Envision is Number 1 in Sussex for the second year running

Envision Pharma Group is delighted to be recognised as the top performing mid-market company and one of the Top 20 fastest-growing businesses in Sussex, having achieved sustained sales growth over the last three years.

Accountancy and business advisory firm BDO LLP’s most recent Best in Business research on the mid-market – which included companies with a turnover of between £10 and £300 million – has revealed Envision Pharma Group to be a real success story in Sussex.

This latest accreditation also shows Envision occupying the number one position in Sussex for the second year running, with a compound annual growth rate of 52% in revenues. BDO’s findings highlight the ongoing importance of such companies to the local economy.

Kevin Cook, Partner at BDO Guildford, commented: “Mid-market companies continue to drive growth in Sussex despite uncertainty caused by the Brexit negotiations. Envision Pharma Group is a great example of a business that, led by a strong management team, continues to embrace market opportunities and is well positioned to take advantage of any opportunities the changing economic landscape presents. We have a tremendous base of entrepreneurial and aspirational companies to be proud of locally.”

Envision Pharma Group’s Chief Strategy Officer, David Thompson, added: “Our efforts to augment the company's position as the leading scientific and technology company in the pharmaceutical services industry to a fully-fledged strategic multichannel partner for our medical affairs clients is starting to gain significant traction. This, in turn, is leading to further opportunities for both our talented staff and to new individuals joining the organisation. It’s a very exciting time.”

Click here to download the Best in Business Surrey and Sussex 2017/18 Report from the BDO Website.

Click here to read the article on the BDO Website.